SALAROLI, ADRIANO
 Distribuzione geografica
Continente #
NA - Nord America 192
EU - Europa 53
AS - Asia 26
AF - Africa 3
Totale 274
Nazione #
US - Stati Uniti d'America 190
IT - Italia 19
SE - Svezia 14
SG - Singapore 11
CN - Cina 8
IN - India 6
DE - Germania 5
GB - Regno Unito 4
BG - Bulgaria 3
FI - Finlandia 3
TG - Togo 3
CA - Canada 2
RO - Romania 2
GR - Grecia 1
IE - Irlanda 1
MY - Malesia 1
UA - Ucraina 1
Totale 274
Città #
Fairfield 43
Woodbridge 18
Ashburn 16
Chandler 16
Seattle 16
Houston 12
Wilmington 12
Cambridge 11
Beijing 7
San Paolo di Civitate 7
Ann Arbor 6
Singapore 6
Princeton 4
Rome 4
Andover 3
Bologna 3
Bremen 3
Lawrence 3
Lomé 3
Milan 3
Millbury 3
Plano 3
Sofia 3
Boston 2
Bühl 2
Ottawa 2
Athens 1
Brugherio 1
Des Moines 1
Dublin 1
Indiana 1
Lappeenranta 1
Nanjing 1
Parma 1
San Diego 1
Southend 1
Totale 221
Nome #
Splenic marginal zone lymphoma : Prognostic factors ,role of watch and wait policy ,and othert herapeutic approaches in the rituximab era 96
Suboptimal response to imatinib according to 2006-2009 European LeukaemiaNet criteria: A 'grey zone' at 3, 6 and 12 months identifies chronic myeloid leukaemia patients who need early intervention 64
null 51
Discontinuation of alpha-interferon treatment in patients with chronic myeloid leukemia in long-lasting complete molecular response 45
Clinical relevance of hypogammaglobulinemia, clinical and biologic variables on the infection risk and outcome of patients with stage A chronic lymphocytic leukemia 17
Independent prognostic impact of CD15 on complete remission achievement in patients with acute myeloid leukemia 16
Totale 289
Categoria #
all - tutte 829
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 829


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202071 0 2 0 3 9 9 12 7 10 8 7 4
2020/202126 4 1 3 0 5 3 2 0 2 5 1 0
2021/202247 0 6 5 3 5 3 1 2 4 4 6 8
2022/202363 8 15 8 6 7 8 4 1 5 0 1 0
2023/202436 2 7 2 5 2 5 1 1 1 1 6 3
2024/20257 2 5 0 0 0 0 0 0 0 0 0 0
Totale 289